Dr. Athira Raveendran is a Postdoctoral Fellow in the Department of Radiology and Biomedical Imaging. At UCSF, Dr. Raveendran focuses on the development and evaluation of novel radioimmunoconjugates for cancer imaging and therapy. Her research integrates molecular design with translational imaging approaches to advance precision oncology. She has extensive experience in coordinating and leading preclinical studies, with a particular emphasis on antibodies and peptide-based radiopharmaceuticals for prostate and bladder cancers.
She completed her PhD in South Korea, where she developed fluorescent-based drug delivery agents and organelle-targeted strategies for cancer imaging and therapy. This work explored targeting the tumor microenvironment to enhance both imaging and therapeutic outcomes.